The rationale for neoadjuvant radiation therapy in malignant pleural mesothelioma: how smart is SMART?

nork Cho, B. C. John
Argitaratua izan da Ann Transl Med (2017)

Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors

nork Westover, D, Zugazagoitia, J, Cho, B C, Lovly, C M, Paz-Ares, L
Argitaratua izan da Ann Oncol (2018)

Outcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer

nork Yung, T., Giuliani, M.E., Le, L.W., Sun, A., Cho, B.C.J., Bezjak, A., Brade, A., Hope, A.J.
Argitaratua 2012

Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.

nork Cho, B C, Shaughnessy, J D, Largaespada, D A, Bedigian, H G, Buchberg, A M, Jenkins, N A, Copeland, N G
Argitaratua 1995

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens

nork Jeung, H-C, Rha, S Y, Cho, B C, Yoo, N C, Roh, J K, Roh, W J, Chung, H C, Ahn, J B
Argitaratua 2006

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy

nork Giuliani, M., Sampson, L.R., Wong, O., Gay, J., Le, L.W., Cho, B.C.J., Brade, A., Sun, A., Bezjak, A., Hope, A.J.
Argitaratua izan da Curr Oncol (2016)

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy

nork Kim, S-M, Kim, H, Yun, M R, Kang, H N, Pyo, K-H, Park, H J, Lee, J M, Choi, H M, Ellinghaus, P, Ocker, M, Paik, S, Kim, H R, Cho, B C
Argitaratua izan da Oncogenesis (2016)

Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy

nork Tagawa, Tetsuzo, Anraku, Masaki, Morodomi, Yosuke, Takenaka, Tomoyoshi, Okamoto, Tatsuro, Takenoyama, Mitsuhiro, Ichinose, Yukito, Maehara, Yoshihiko, Cho, B. C. John, Feld, Ronald, Tsao, Ming-Sound, Leighl, Natasha, Bezjak, Andrea, Keshavjee, Shaf, de Perrot, Marc
Argitaratua izan da J Thorac Dis (2015)

Dabrafenib in BRAF V600E–Mutant Advanced Non-Small Cell Lung Cancer: an Open-label, Single arm, Multicenter, Phase 2 Trial

nork Planchard, David, Kim, Tae Min, Mazieres, Julien, Quoix, Elisabeth, Riely, Gregory, Barlesi, Fabrice, Souquet, Pierre-John, Smit, Egbert F., Groen, Harry J. M., Kelly, Ronan J., Cho, B. C., Socinski, Mark A., Pandite, Lini, Nase, Christine, Ma, Bo, D’Amelio, Anthony, Mookerjee, Bijoyesh, Curtis, C. Martin, Johnson, Bruce E.
Argitaratua izan da Lancet Oncol (2016)

A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis

nork Yan, Michael, Sigurdson, Samantha, Greifer, Noah, Kennedy, Thomas A. C., Toh, Tzen S., Lindsay, Patricia E., Weiss, Jessica, Hueniken, Katrina, Yeung, Christy, Sugumar, Vijithan, Sun, Alexander, Bezjak, Andrea, Cho, B. C. John, Raman, Srinivas, Hope, Andrew J., Giuliani, Meredith E., Stuart, Elizabeth A., Owen, Timothy, Ashworth, Allison, Robinson, Andrew, de Moraes, Fabio Ynoe, Liu, Geoffrey, Lok, Benjamin H.
Argitaratua izan da Cancers (Basel) (2021)